EMIT II PLUS BENZODIAZEPINE ASSAY, MODEL 0SR9F229

Enzyme Immunoassay, Benzodiazepine

SYVA CO., DADE BEHRING, INC.

The following data is part of a premarket notification filed by Syva Co., Dade Behring, Inc. with the FDA for Emit Ii Plus Benzodiazepine Assay, Model 0sr9f229.

Pre-market Notification Details

Device IDK011306
510k NumberK011306
Device Name:EMIT II PLUS BENZODIAZEPINE ASSAY, MODEL 0SR9F229
ClassificationEnzyme Immunoassay, Benzodiazepine
Applicant SYVA CO., DADE BEHRING, INC. 3403 YERBA BUENA RD. San Jose,  CA  95135
ContactCynthia Arredono
CorrespondentCynthia Arredono
SYVA CO., DADE BEHRING, INC. 3403 YERBA BUENA RD. San Jose,  CA  95135
Product CodeJXM  
CFR Regulation Number862.3170 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeSpecial
3rd Party ReviewedNo
Combination ProductNo
Date Received2001-04-30
Decision Date2001-05-16

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
00842768023392 K011306 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.